AZ Duette- A Phase 2 Randomized, Multi-Centre Study to Investigate the Efficacy and Tolerability of a Second Maintenance Treatment in Patients With Platinum Sensitive Relapsed Epithelial Ovarian Cancer, Who Have Previously Received PARP Inhibitor Maintenance Treatment

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/record/NCT04239014?term=NCT04239014&draw=2&rank=1

Clinical Trial Categories

• Ovarian Cancer

Contact

Ashley Douglas, RN at 215-481-4429